The US Food and Drug Administration has approved a blood test to be used for colorectal cancer screening among average-risk adults 45 and older. The maker of the test, Palo Alto, California-based ...
Mail-based screening programs are helping more Americans stay up to date with colorectal cancer tests—often with a simple box delivered at home.
OVER a quarter of people in the region eligible for bowel cancer screening don't complete their test, new figures show.
Broad endorsement for insurance-covered blood-based CRC screening (92%) suggests payer policy could materially influence uptake among guideline-eligible, average-risk adults starting at age 45.
The test, which screens for DNA that is released when cancer cells die, is now one of multiple options for colorectal cancer screening. Guardant Health's Shield blood test for colorectal cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results